About Kaveri Parker
Kaveri Parker is a chief business officer at Alume Biosciences.
Form D filings also name Kaveri Parker as an executive officer at Synedgen.
Kaveri Parker first appears on SEC filings in 2024.
Experience
This experience comes from Kaveri Parker's profile and from SEC filings. For roles taken from filings, the years are when the filings name Kaveri Parker in the role, so the role may have started earlier or lasted longer.
Alume Biosciences Inc Current
Chief Business Officer
2025 – Present · LA Jolla, CA
Develops drugs to help surgeons see nerves during operations.
MC
Mayo Clinic
Strategic Advisor
2021 – 2026
II
ID Genomics, Inc.
President and CEO
2015 – 2018
WM
Washington University School of Medicine
Postdoctoral Research Fellow
2007 – 2015
Key Colleagues at Startups
The people Kaveri Parker works with at each company, as listed on that company's latest Form D.
Alume Biosciences Inc · Form D/A, May 8, 2026
Kim Kamdar
Board Member
Jean-Pierre Millon
Board Member
Brett Berman
Chief Medical Officer and director
Dan Bradbury
Executive Chair
James Schmidt
Chief Financial Officer
Quyen Nguyen
Chief Executive Officer and director
Magda Marquet
Board Member
Synedgen, Inc. · Form D, Oct 1, 2024
SB
Shenda Baker
Chief Executive Officer and President, director
WW
William Wiesmann
Executive officer and director
PG
Paul Grint
Director
HO
Hal Oien
Director
AM
Andrew Miller
Director
DB
Daniel Bradbury
Director
KG
Kenton Gregory
Director